A Study to Assess the Mass Balance Recovery and Metabolite Profile & Identification of [14C]-APX001 in Healthy Males
Clinical trial NCT04804059 · COMPLETED
Trial details
- NCT number
- NCT04804059
- Sponsor
- Basilea Pharmaceutica
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-17
- Primary completion
- 2018-09-26
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.